Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. (COGT) is a healthcare company (biotechnology) based in the United States. The share price is $26.90, down 1.97% on the day, which values the company at $4.68B. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$26.90−1.97% today
Market value
$4.68B
200-week average
$16.5163% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Cogent Biosciences, Inc. in more detail

COGT trades at -21.2× next year's expected earnings. It sits 63% above its 200-week average of $16.51.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold COGT, including Andrew Spokes (0.0% of the portfolio).

Superinvestors holding COGT

1 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:COGT vs GRAL (Cogent Biosciences, Inc. vs GRAIL)COGT vs GRFS (Cogent Biosciences, Inc. vs Grifols)COGT vs MANE (Cogent Biosciences, Inc. vs Veradermics)COGT vs MIRM (Cogent Biosciences, Inc. vs Mirum Pharmaceuticals)COGT vs TFX (Cogent Biosciences, Inc. vs Teleflex)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Cogent Biosciences, Inc. (COGT): questions and answers

What is Cogent Biosciences, Inc.'s market cap?

Cogent Biosciences, Inc. is valued at $4.68B at a share price of $26.90.

Is COGT above its 200-week moving average?

Yes. COGT is 62.9% above its 200-week average of $16.51. Long-term investors watch that line because strong companies rarely trade below it for long.

Does COGT pay a dividend?

Cogent Biosciences, Inc. does not currently pay a regular dividend.

Which famous investors own COGT?

In their latest quarterly filings, Andrew Spokes (0.0% of the portfolio) hold COGT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Cogent Biosciences, Inc. (COGT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/COGT

Underlying data: Yahoo Finance; company filings with the SEC.